Get the Stockscreener App
2.84
10.41%
-0.33
Silexion Therapeutics Corp stock is traded at $2.84, with a volume of 74,139.
It is down -10.41% in the last 24 hours and down -27.74% over the past month.
Silexion Therapeutics Corp a clinical-stage, oncology-focused biotechnology company engaged in the discovery and development of proprietary treatments for KRAS-driven cancers. The KRAS gene is an oncogene that is involved in the regulation of cell division as a result of its ability to relay external signals into the cell. Its product candidate, SIL204, consists of locally administered small interfering RNAs, or siRNA, in a solution, as a first-line treatment of locally advanced pancreatic cancer patients, or LAPC, in combination with standard-of-care chemotherapy. It is currently focused on treatment for pancreatic cancer tumors bearing the KRAS G12D or KRAS G12V mutations where metastases have not been detected and are non-resectable, i.e. it is not able to be surgically removed.
See More
Previous Close:
$3.17
Open:
$3.08
24h Volume:
74,139
Relative Volume:
0.16
Market Cap:
$2.17M
Revenue:
-
Net Income/Loss:
$-17.85M
P/E Ratio:
-0.0766
EPS:
-37.0644
Net Cash Flow:
$-13.02M
1W Performance:
-17.20%
1M Performance:
-27.74%
6M Performance:
-81.07%
1Y Performance:
-91.64%
1-Day Range:
$2.93
$3.14
1-Week Range:
$2.93
$3.47
52-Week Range:
$2.93
$63.45
Silexion Therapeutics Corp Stock (SLXN) Company Profile
Name
Silexion Therapeutics Corp
Sector
Industry
Phone
972-8-6286005
Address
12 ABBA HILLEL ROAD, RAMAT GAN
Compare SLXN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SLXN
Silexion Therapeutics Corp
|
2.96 | 9.91M | 0 | -17.85M | -13.02M | -37.06 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.79 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
630.47 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
425.88 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
839.45 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.41 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Silexion Therapeutics Corp Stock (SLXN) Latest News
Can Silexion Therapeutics Corp hit a new high this monthWeekly Trend Recap & Short-Term Swing Trade Alerts - newser.com
Momentum divergence signals in Silexion Therapeutics Corp chartJuly 2025 Market Mood & Proven Capital Preservation Methods - newser.com
Will Silexion Therapeutics Corp Equity Warrant price bounce be sustainableJuly 2025 Trade Ideas & Daily Chart Pattern Signal Reports - newser.com
Relative strength of Silexion Therapeutics Corp in sector analysisQuarterly Growth Report & Fast Entry Momentum Trade Alerts - newser.com
Will Silexion Therapeutics Corp outperform the marketQuarterly Profit Report & Growth Focused Entry Reports - newser.com
Is Silexion Therapeutics Corp stock oversold or undervaluedChart Signals & Capital Protection Trade Alerts - newser.com
Can Silexion Therapeutics Corp Equity Warrant recover in the next quarterMarket Weekly Review & AI Powered Buy/Sell Recommendations - newser.com
Detecting price anomalies in Silexion Therapeutics Corp with AI2025 Market Overview & Real-Time Volume Analysis Alerts - newser.com
Can Silexion Therapeutics Corp Equity Warrant stock rebound after recent weakness2025 Short Interest & Daily Risk Controlled Trade Plans - newser.com
Can Silexion Therapeutics Corp stock maintain growth trajectoryPortfolio Profit Report & Daily Oversold Bounce Ideas - newser.com
How sentiment analysis helps forecast Silexion Therapeutics CorpJuly 2025 Rallies & Free Safe Entry Trade Signal Reports - newser.com
What does recent volatility data suggest for Silexion Therapeutics Corp2025 Earnings Surprises & Safe Entry Momentum Tips - newser.com
Will Silexion Therapeutics Corp stock remain a Wall Street favoriteEarnings Risk Report & Real-Time Volume Spike Alerts - newser.com
Real time alert setup for Silexion Therapeutics Corp Equity Warrant performance2025 Big Picture & Short-Term High Return Strategies - newser.com
Applying Elliott Wave Theory to Silexion Therapeutics Corp Equity Warrant2025 Key Lessons & Reliable Breakout Forecasts - newser.com
Technical analysis overview for Silexion Therapeutics Corp stockMarket Movement Recap & High Accuracy Buy Signal Tips - newser.com
Applying sector rotation models to Silexion Therapeutics Corp Equity WarrantJuly 2025 Intraday Action & Low Drawdown Investment Strategies - newser.com
Has Silexion Therapeutics Corp formed a bullish divergence2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Why Silexion Therapeutics Corp Equity Warrant stock is trending among retail traders2025 Trade Ideas & Accurate Buy Signal Notifications - newser.com
Momentum divergence signals in Silexion Therapeutics Corp Equity Warrant chartWeekly Trend Report & Accurate Intraday Trading Signals - newser.com
Can Silexion Therapeutics Corp Equity Warrant stock withstand economic slowdownWeekly Market Summary & Real-Time Volume Triggers - newser.com
Will Silexion Therapeutics Corp Equity Warrant stock benefit from commodity pricesWeekly Profit Summary & Risk Managed Investment Strategies - newser.com
Risk adjusted return profile for Silexion Therapeutics Corp Equity Warrant analyzedQuarterly Earnings Summary & Reliable Price Breakout Signals - newser.com
Why retail investors pile into Silexion Therapeutics Corp Equity Warrant stockQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
How to read the order book for Silexion Therapeutics Corp2025 Trading Recap & AI Driven Price Predictions - newser.com
Will a bounce in Silexion Therapeutics Corp offer an exit2025 Stock Rankings & Real-Time Volume Triggers - newser.com
Identifying reversal signals in Silexion Therapeutics Corp Equity WarrantBear Alert & Verified Trade Idea Suggestions - newser.com
Will Silexion Therapeutics Corp Equity Warrant stock gain from strong economyMarket Risk Report & Free High Accuracy Swing Entry Alerts - newser.com
Silexion Therapeutics Corp (SLXN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
How Silexion Therapeutics Corp Equity Warrant stock performs in high volatility marketsJuly 2025 Summary & Safe Capital Preservation Plans - newser.com
Will Silexion Therapeutics Corp stock benefit from infrastructure spending2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
Silexion Therapeutics Corp stock volume spike explainedTrade Risk Report & Risk Controlled Daily Plans - newser.com
[S-3] Silexion Therapeutics Corp Shelf Registration Statement | SLXN SEC FilingForm S-3 - Stock Titan
Will Silexion Therapeutics Corp Equity Warrant outperform the market2025 Historical Comparison & Reliable Trade Execution Plans - newser.com
Silexion Therapeutics Corp Stock (SLXN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.41%
0.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):